
NurExone Biologic (TSXV: NRX) (Germany: J90)
@NBiologic
Followers
366
Following
85
Media
53
Statuses
148
NurExone Biologic (TSXV: $NRX) is developing a revolutionary treatment for the treatment of paralysis following Spinal Cord Injury using extracellular vesicles
Joined May 2021
Florida 🌴 is emerging as a leader in regenerative medicine, with new laws supporting exosome use in wellness. A timely setting for the 2nd Global Cell & Gene Therapy Summit, where Lior Shaltiel, PhD presented — a big moment for NurExone. #CGTSummit #Exosomes #Biotech #Florida
1
0
7
📢 Join our presentation at the Investor Summit Group online meeting on June 10, 2025 at 2:00 PM EDT 🗓️. 💻 To request free registration for this exclusive investor event focused on small and microcap stocks, go to: . See you at the Summit!!.
investorsummitgroup.com
Q2 Virtual Investor SummitEvent June 10, 2025 Presentation 9:00am – 5:00pm ET June 11, 2025 1×1 Meeting 9:00am – 5:00pm ET REGISTER AS AN INVESTOR Q2 2025 Presenters Microcap Companies Click on...
0
0
8
Thanks to Danny Lieberman for hosting Lior Shaltiel, PhD for a fascinating discussion about life, exosomes, regeneration of nerves and more on the Life Sciences Today podcast.
healthcareittoday.com
We're excited to be back for another episode of the Life Sciences Today Podcast by Healthcare IT Today. This time I am with Dr. Lior Shaltiel, Founder and CEO
0
1
4
"For me, the question of where to develop our groundbreaking nerve regeneration technology was never really a dilemma. Our innovation was born in Israel, emerging from 2 elite universities". Dr. Lior Shaltiel, CEO of NurExone.
mako.co.il
על רקע מלחמה מתמשכת ועזיבה של אלפי עובדי הייטק, חברות טכנולוגיה ישראליות מתחבטות בשאלה מאיפה כדאי להן לפעול - מהארץ או מעבר לים. ארבעה מנכ"לים שמנהלים חברות עם לקוחות ועובדים מהעולם, מספרים ל-mako על...
1
0
4
Increasing engagement with the European investment and healthcare communities this May!. 1️⃣ INVEST 2025 – Stuttgart (May 9-10). 2️⃣ Healthtech Roadshow – Zurich (May 5-8). 3️⃣ BioProcess International Europe – Hamburg (May 12-15).
globenewswire.com
NurExone Expands European Engagement with Investor Events in Germany and Switzerland...
0
2
4
ICYMI - Successfully closed a C$2.3M raise that will help:. 🟦 Advance our clinical development .🟧 Drive U.S. expansion.🟨 Support our uplisting strategy. Next steps: U.S. growth and clinical impact. #RealMomentum #ExoPTEN #Exosomes
0
3
5
🚨 Exciting News from Vienna!. NurExone Biologic is proud to be attending the #ISEV2025 Meeting from April 24–27, 2025 in Vienna, Austria. Let’s discuss how we’re transforming possibilities in neural repair and beyond. See you there! 🌍💡
0
0
4
Preclinical study assessing two ExoPTEN dosing regimens demonstrated strong potential for spinal cord injury recovery—advancing towards IND submission and first-in-human trials! .
globenewswire.com
ExoPTEN’s Preclinical Study Demonstrates Significant for Enhancing Motor Function, Increasing Blood Flow, and Faster Recovery After Spinal Cord Injuries...
0
2
7